Endotoxemia and release of tumor necrosis factor and interleukin 1 alpha in acute heatstroke. 1991

A Bouchama, and R S Parhar, and A el-Yazigi, and K Sheth, and S al-Sedairy
Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

To determine whether endotoxemia and release of tumor necrosis factor (TNF-alpha) and/or interleukin 1 alpha (IL-1 alpha) are involved in the pathogenesis of heatstroke, 17 adult patients with a mean rectal temperature of 42.1 +/- 0.2 degrees C were studied. Blood samples were taken on admission and after cooling was completed. TNF-alpha and IL-1 alpha levels were measured by enzyme-linked immunosorbent assay, and lipopolysaccharide (LPS) content was measured by the chromogenic substrate modification of the Limulus amebocyte lysate. TNF-alpha, IL-1 alpha, and LPS were elevated in all patients [199 +/- 25 (SE) pg/ml, 480.5 +/- 68.3 pg/ml, and 8.60 +/- 1.19 ng/ml, respectively, compared with normal control values of 31.4 +/- 8.4 pg/ml, 53.7 +/- 5.32 pg/ml, and less than 9 pg/ml]. There was no significant correlation between temperature and the circulating concentration of TNF-alpha, IL-1 alpha, and LPS. Postcooling TNF-alpha, IL-1 alpha, and LPS concentrations were significantly decreased but still above normal control values. The findings suggest that these mediators may have a role in the pathogenesis of heatstroke that could change the strategy of management.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D005260 Female Females
D006359 Heat Exhaustion A clinical syndrome caused by heat stress, such as over-exertion in a hot environment or excessive exposure to sun. It is characterized by SWEATING, water (volume) depletion, salt depletion, cool clammy skin, NAUSEA, and HEADACHE. Heat Collapse,Heat Prostration,Collapse, Heat,Exhaustion, Heat,Prostration, Heat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014115 Toxemia A condition produced by the presence of toxins or other harmful substances in the BLOOD. Toxemias
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

A Bouchama, and R S Parhar, and A el-Yazigi, and K Sheth, and S al-Sedairy
February 1993, The Journal of experimental medicine,
A Bouchama, and R S Parhar, and A el-Yazigi, and K Sheth, and S al-Sedairy
February 1996, The Journal of clinical investigation,
A Bouchama, and R S Parhar, and A el-Yazigi, and K Sheth, and S al-Sedairy
June 1991, Archives of dermatology,
A Bouchama, and R S Parhar, and A el-Yazigi, and K Sheth, and S al-Sedairy
January 1995, Journal of clinical immunology,
A Bouchama, and R S Parhar, and A el-Yazigi, and K Sheth, and S al-Sedairy
March 1994, Infection and immunity,
A Bouchama, and R S Parhar, and A el-Yazigi, and K Sheth, and S al-Sedairy
November 1990, International journal of cancer,
A Bouchama, and R S Parhar, and A el-Yazigi, and K Sheth, and S al-Sedairy
February 1993, The Journal of infectious diseases,
A Bouchama, and R S Parhar, and A el-Yazigi, and K Sheth, and S al-Sedairy
November 1992, Journal of vascular surgery,
A Bouchama, and R S Parhar, and A el-Yazigi, and K Sheth, and S al-Sedairy
January 1994, Immunopharmacology,
A Bouchama, and R S Parhar, and A el-Yazigi, and K Sheth, and S al-Sedairy
February 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Copied contents to your clipboard!